Connection

Philip Privitera to Blood Pressure

Back to Details
This is a "connection" page, showing publications Philip Privitera has written about Blood Pressure.
Philip Privitera
Connection Strength
0.422
Blood Pressure
  1. Rostral ventrolateral medulla as a site for the central hypertensive action of kinins. Hypertension. 1994 Jan; 23(1):52-8.
    View in: PubMed
    Score: 0.072
  2. Brain kallikrein-kinin system in arterial pressure regulation. Agents Actions Suppl. 1992; 38 ( Pt 3):39-46.
    View in: PubMed
    Score: 0.063
  3. A stereoselective central hypotensive action of atenolol. J Pharmacol Exp Ther. 1989 Sep; 250(3):759-63.
    View in: PubMed
    Score: 0.053
  4. C1 area of the rostral ventrolateral medulla as a site for the central hypotensive action of propranolol. J Pharmacol Exp Ther. 1988 Aug; 246(2):529-33.
    View in: PubMed
    Score: 0.049
  5. Site and mechanism of the centrally mediated hypotensive action of propranolol. J Pharmacol Exp Ther. 1985 Oct; 235(1):66-70.
    View in: PubMed
    Score: 0.041
  6. Cerebroventricular propranolol elevates cerebrospinal fluid norepinephrine and lowers blood pressure. Science. 1981 Aug 21; 213(4510):911-3.
    View in: PubMed
    Score: 0.030
  7. Effects of centrally administered propranolol on plasma renin activity, plasma norepinephrine and arterial pressure. Eur J Pharmacol. 1979 Feb 15; 54(1-2):51-60.
    View in: PubMed
    Score: 0.026
  8. Cerebrospinal fluid kallikrein in spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats. J Hypertens. 1993 Oct; 11(10):1039-45.
    View in: PubMed
    Score: 0.018
  9. A comparison of the cardiovascular effects of biogenic amines and their precursors in newborn and adult dogs. J Pharmacol Exp Ther. 1969 Apr; 166(2):293-8.
    View in: PubMed
    Score: 0.013
  10. Afferent vagal stimulation, vasopressin, and nitroprusside alter cerebrospinal fluid kinin. Am J Physiol. 1987 Jul; 253(1 Pt 2):R136-41.
    View in: PubMed
    Score: 0.011
  11. Cardiovascular and myocardial metabolic effects of infusions of phenylephrine. J Pharmacol Exp Ther. 1967 May; 156(2):325-30.
    View in: PubMed
    Score: 0.011
  12. Persistence of myocardial failure following removal of chronic volume overload. Am J Physiol. 1982 Dec; 243(6):H876-83.
    View in: PubMed
    Score: 0.008
  13. A metabolic fragment of bradykinin, Arg-Pro-Pro-Gly-Phe, protects against the deleterious effects of lipopolysaccharide in rats. J Pharmacol Exp Ther. 2001 Jan; 296(1):71-6.
    View in: PubMed
    Score: 0.007
  14. Hypertensive effect of tissue kallikrein in rostral ventrolateral medulla is mediated by brain kinins. Brain Res. 1995 Dec 15; 704(1):103-6.
    View in: PubMed
    Score: 0.005
  15. Adrenergic blocking and cardiovascular effects of a new N-substituted tetrahydroisoquinoline (NC 7197). J Pharmacol Exp Ther. 1971 Mar; 176(3):655-61.
    View in: PubMed
    Score: 0.004
  16. Effect of methyldopa on plasma renin activity in man. Circ Res. 1969 Nov; 25(5):543-8.
    View in: PubMed
    Score: 0.003
  17. Time course of development of the antihypertensive effect of propranolol. Hypertension. 1983 Nov-Dec; 5(6):852-7.
    View in: PubMed
    Score: 0.002
  18. Childhood familial and racial differences in physiologic and biochemical factors related to hypertension. Hypertension. 1983 Jan-Feb; 5(1):56-70.
    View in: PubMed
    Score: 0.002
  19. Effects of perhexiline on survival time and infarct size in experimental myocardial infarction. J Pharmacol Exp Ther. 1977 Jan; 200(1):155-65.
    View in: PubMed
    Score: 0.001
  20. Cardiovascular actions of a new metabolite of propranolol: isopropylamine. J Pharmacol Exp Ther. 1974 Jun; 189(3):626-32.
    View in: PubMed
    Score: 0.001
  21. Hemodynamic effects of phenoxybenzamine in anesthetized dogs. J Clin Invest. 1970 Nov; 49(11):2036-50.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.